Spectral Medical, Inc. (EDT.TO)
1.00
-0.08
(-7.41%)
CAD |
TSX |
Oct 23, 16:00
Spectral Medical Max Drawdown (5Y) : 74.40% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 74.40% |
| August 31, 2026 | 82.80% |
| July 31, 2026 | 83.33% |
| June 30, 2026 | 83.33% |
| May 31, 2026 | 83.33% |
| April 30, 2026 | 83.33% |
| March 31, 2026 | 83.33% |
| February 28, 2026 | 83.33% |
| January 31, 2026 | 83.33% |
| December 31, 2025 | 83.33% |
| November 30, 2025 | 83.33% |
| October 31, 2025 | 83.33% |
| September 30, 2025 | 83.33% |
| August 31, 2025 | 83.33% |
| July 31, 2025 | 83.33% |
| June 30, 2025 | 83.33% |
| May 31, 2025 | 83.33% |
| April 30, 2025 | 83.33% |
| March 31, 2025 | 83.33% |
| February 28, 2025 | 83.33% |
| January 31, 2025 | 83.33% |
| December 31, 2024 | 83.33% |
| November 30, 2024 | 83.33% |
| October 31, 2024 | 83.33% |
| September 30, 2024 | 83.33% |
| Date | Value |
|---|---|
| August 31, 2024 | 83.33% |
| July 31, 2024 | 83.33% |
| June 30, 2024 | 83.33% |
| May 31, 2024 | 83.33% |
| April 30, 2024 | 83.33% |
| March 31, 2024 | 83.33% |
| February 29, 2024 | 83.33% |
| January 31, 2024 | 83.86% |
| December 31, 2023 | 85.19% |
| November 30, 2023 | 88.36% |
| October 31, 2023 | 88.36% |
| September 30, 2023 | 88.36% |
| August 31, 2023 | 88.36% |
| July 31, 2023 | 88.36% |
| June 30, 2023 | 88.36% |
| May 31, 2023 | 88.36% |
| April 30, 2023 | 88.36% |
| March 31, 2023 | 88.36% |
| February 28, 2023 | 88.36% |
| January 31, 2023 | 88.36% |
| December 31, 2022 | 88.36% |
| November 30, 2022 | 88.36% |
| October 31, 2022 | 88.36% |
| September 30, 2022 | 88.36% |
| August 31, 2022 | 88.36% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Resverlogix Corp. | 98.85% |
| Theratechnologies, Inc. | 97.05% |
| COSCIENS Biopharma, Inc. | 99.36% |
| Restart Life Sciences Corp. | 99.48% |
| Defence Therapeutics Inc | 95.49% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 23.07 |
| Beta (5Y) | 0.1866 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.42% |
| Historical Sharpe Ratio (5Y) | 0.4028 |
| Historical Sortino (5Y) | 1.052 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.39% |